Niloufar Hooshyar
1 , Mehrnoosh Sedighi
2 , Masoomeh Hooshmand
3 , Rohollah Valizadeh
4 , Semko Ebrahimi
5 , Mohammadreza Khosravifarsani
6* , Behzad Ghasemi
7 , Nafiseh Nowrouzi
7 , Parto Nasri
8 1 Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khoramabad, Iran
3 Department of Environmental Engineering, Istanbul Technical University, Istanbul, Turkey
4 Department of Epidemiology, Student Research Committee, School of Public Health, Iran University of Medical science, Tehran, Iran
5 Department of Anesthesiology, Health North gGmbH Klinikverbund Bremen, Hospital left of the Weser (klinkum Links der Weser) (Senator-Weßling-Straße 1; 28277), Bremen, Germany
6 Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
7 Faculty of pharmacy, Pécs University, Pecs, Hungary
8 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Cisplatin is a powerful chemotherapy drug that is administered to treat a wide range of cancers. However,
its clinical use is limited due to kidney damage and the reduction in glomerular filtration rate that occurs
in 15% to 30% of patients. Several mechanisms lead to renal dysfunction after cisplatin administration,
including direct damage to proximal tubular epithelial cells that causes necrosis and apoptosis. Cisplatin
administration is accompanied by the production of reactive oxygen species (ROS), which causes lipid
peroxidation, proteins and nucleic acids oxidation, cell membrane degradation, and finally reduction in
glomerular filtration. The most prominent effect of cisplatin-induced nephrotoxicity (CIN), which can be
progressive, is hypomagnesemia, Fanconi syndrome and anemia. Cisplatin nephrotoxicity is more prominent
in individuals who received higher doses of this drug, or in patients who had previous chemotherapy
regimen and presence of renal dysfunction. This paper is sought to describe cisplatin nephrotoxicity and the
protective role of medicinal plants in preventing the renal toxicity. In this regard, the role of antioxidants
will be specifically addressed.